Design, Synthesis and Structure of Peptides and Proteins news

<p>"Art Made of Science – Microspheres". Source: Quo Artis</p>
5 Feb 2019

From 12/02 to 12/03, the Artist in Residence, Ayse Güll Süter, will be exhibiting her work: “Art made of Science-Microspheres” at the Sant Pau Art Nouveau Site (Recinto Modernista de Sant Pau).

This project has been done in collaboration with the Fundación Quo Artis, the Sant Pau Art Nouveau Site, and IRB Barcelona.

<p>Biennal Ciutat i Ciència</p>
16 Jan 2019

From 7 to 11 February, the general public will have the opportunity to participate in activities related to ageing, nanoscience and climate change, among others.

IRB Barcelona will be taking part in the Biennal event through three initiatives that target the public.

<p>Biennal Ciutat i Ciència</p>
16 Jan 2019

From 7 to 11 February, the general public will have the opportunity to participate in activities related to ageing, nanoscience and climate change, among others.

IRB Barcelona will be taking part in the Biennal event through three initiatives that target the public.

<p>Giant Yellow Israeli scorpion. Image: Ester Inbar</p>
8 Jan 2019

RNE's "Inquietamente" programme has interviewed Meritxell Teixidó, IRB Barcelona research associate, about the study based on scorpion venom. "We saw that there was a peptide in the scorpion venom, chlorotoxin, which has the ability to reach the central nervous system and then act as toxin, "said Teixidó.

Link to RNE

 

<p>Teresa Tarragó. Image: El Periódico</p>
7 Dec 2018

Expansión, El Periódico de Catalunya and Diario de Córdoba, among other media, have published articles about the biotechnologist Iproteos, a company created in 2011 by the scientists Teresa Tarragó and Ernest Giralt and based on the transfer of a technology developed atIRB Barcelona and the University of Barcelona (UB). The company has launched a project to develop a therapeutic strategy, designed by IBEC, to treat solid tumours, which account for 90-95% of cancer cases.

Link to El Periódico de Catalunya...

<p>Source: IRB Barcelona</p>
15 Nov 2018

TV3, RAC1, ABC, World Pharma News, Neuro Science, among other national and international media, have published articles about the research from the Peptides and Proteins Lab at IRB Barcelona. The study in question is inspired on the scorpion venom to deliver medicines to brain. The scientists have modified a peptide from the venom and used it as a shuttle to transport drugs across the barrier that protects the brain.

Link to TV3

Link to...

<p>Giant Yellow Israeli scorpion. Image: Ester Inbar</p>
14 Nov 2018

Researchers at IRB Barcelona modify chlorotoxin—a small protein present in scorpion venom with blood-brain barrier permeability—to transport drugs into the brain. 

The barrier, which protects the brain, prevents drugs used for the treatment of neurological diseases and brain tumours from entering the organ.

<p>Ernest Giralt receives the diploma at La Marató ceremony</p>
2 Nov 2018

The project presented by Ernest Giralt (IRB Barcelona) and Jordi Vila (ISGLOBAL) has been awarded € 260,000.

Of the 214 projects that applied for funding, 36 were selected on the basis of the evaluation of 103 scientists.

This is the third time that the IRB Barcelona researcher has received funding from “La Marató”.

<p>Source: TV3</p>
10 Oct 2018

La Razón, TV3, La Sexta, Men's Health and New Atlas, among other local and international media, have published an article about the study done at IRB Barcelona and Vrije Universiteiti Brussel. The study has identified camelid nanobodies able to block EGF, a protein that is abundant in tumour cells and that helps them to proliferate.

Link to TV3

Link to...

<p>Figure showing the binding of a nanobody derived from alpaca to the EGF protein. The scientists demonstrate the high affinity and selectivity of a family of nanobodies for EGF, target of interest for the treatment of cancer (S Guardiola, IRB Barcelona)</p>
2 Oct 2018

A study done at IRB Barcelona and the Vrije Universiteit Brussel identifies camelid nanobodies able to block EGF, a protein that is abundant in tumour cells and that helps them to proliferate.